CONCURRENT TAMOXIFEN (TAM) PLUS CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL (CEF) VERSUS TAM PLUS DELAYED CEF AFTER 6 MONTHS OF ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL FROM THE DANISH BREAST-CANCER COOPERATIVE GROUP (DBCG)

Authors
PFEIFFER P ROSE C EJLERTSEN B ANDERSSON M PEDERSEN D MOURIDSEN HT
Citation
P. Pfeiffer et al., CONCURRENT TAMOXIFEN (TAM) PLUS CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL (CEF) VERSUS TAM PLUS DELAYED CEF AFTER 6 MONTHS OF ENDOCRINE THERAPY IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL FROM THE DANISH BREAST-CANCER COOPERATIVE GROUP (DBCG), Acta oncologica, 35(5), 1996, pp. 57-57
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Acta oncologica → ACNP
ISSN journal
0284186X
Volume
35
Issue
5
Year of publication
1996
Supplement
5
Pages
57 - 57
Database
ISI
SICI code
0284-186X(1996)35:5<57:CT(PCE>2.0.ZU;2-K